The Functional Outcomes Core (FC) of the Center for Neurocognition and Emotion in Schizophrenia will serve two purposes. First, it will be an infrastructure element that will provide a range of service functions for the Center's scientific activities. The goal of these services will be to provide the Center with the best strategies for measuring psychosocial and functional outcomes for individuals with schizophrenia. Second, it will establish a scientific agenda focused on the continued development and psychometric testing of measures relevant to functional outcomes in schizophrenia. The FC will have eight aims that include both service aims and scientific aims. There will be six service aims. 1. To house and maintain a set of measures that can be used by studies in the Center when they require functional outcome assessments. These measures will reflect a conceptual model of functional outcome that will be intrinsic to the FC. 2. To serve as the training unit for research personnel who will use the functional outcome measures across projects in the Center. 3. To have a series of quality assurance and data monitoring protocols that can be used to maintain data quality throughout the course studies in the Center. 4. To provide ongoing consultation to studies while they are in the data-gathering phase related to any of the instruments that are supported by the FC. 5. To assist investigators in constructing data elements and constructs from a range of functional outcome data that are common across studies, or that might be uniquely required by certain studies in the Center. 6. To facilitate a series of discussion seminars where various Center investigators can come together to discuss the Center's evolving needs when it comes to functional outcome assessment, as well as to assist the FC in maintaining the most relevant functional outcome assessment protocols. The scientific agenda of the FC will encompass two aims that are critical to the field of functional outcome assessment for individuals with schizophrenia. 7. To further specify and develop a set of functional assessment measures and measurement models that represent constructs that are meaningful to clinical, behavioral, and biosocial studies in schizophrenia. 8. To continue to assess the psychometric viability of the Core measures, paying particular attention to ecological validity, and the invariance of these measures and measurement models across samples, across time in longitudinal studies, and across phases of the disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
1P50MH066286-01A1
Application #
6812811
Study Section
Special Emphasis Panel (ZMH1-NRB-Q (06))
Project Start
2003-09-19
Project End
2008-06-30
Budget Start
2003-09-19
Budget End
2004-06-30
Support Year
1
Fiscal Year
2003
Total Cost
$99,870
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Lee, Junghee; Nuechterlein, Keith H; Knowlton, Barbara J et al. (2018) Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia. Schizophr Bull 44:620-630
Velthorst, Eva; Meyer, Eric C; Giuliano, Anthony J et al. (2018) Neurocognitive profiles in the prodrome to psychosis in NAPLS-1. Schizophr Res :
Chen, Qiaolin; Sugar, Catherine A; Weiss, Robert E (2018) A Bayesian confirmatory factor model for multivariate observations in the form of two-way tables of data. Stat Med 37:1696-1710
Hamilton, Holly K; Williams, Terrance J; Ventura, Joseph et al. (2018) Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia. Am J Psychiatry 175:275-283
Clayson, Peter E; Kern, Robert S; Nuechterlein, Keith H et al. (2018) Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia. Schizophr Res :
Hampton, Joya N; Trotman, Hanan D; Addington, Jean et al. (2018) The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis. Stress Health 34:591-600
Kline, Emily R; Seidman, Larry J; Cornblatt, Barbara A et al. (2018) Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res 192:357-363
Fernandez, Vindia G; Asarnow, Robert; Narr, Katherine L et al. (2018) Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia. Schizophr Res 199:221-225
Woodberry, Kristen A; Seidman, Larry J; Bryant, Caitlin et al. (2018) Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. J Clin Child Adolesc Psychol 47:69-78
Grazioplene, Rachael G; Bearden, Carrie E; Subotnik, Kenneth L et al. (2018) Connectivity-enhanced diffusion analysis reveals white matter density disruptions in first episode and chronic schizophrenia. Neuroimage Clin 18:608-616

Showing the most recent 10 out of 146 publications